

CloSys Corporation
CloSys is testing in a U.S. pivotal trial a vascular closure system designed to meet all the requirements of a $1 billion per year market.
- Stage Full Product Ready
- Industry Medical Devices and Equipment
- Location United States
- Currency USD
- Founded March 2005
- Employees 2
- Website closyscorp.com
Company Summary
CloSys has developed a product that is used to seal a large arterial puncture wound created to allow access to heart and peripheral arteries for interventional procedures such as angioplasty or stent placement. The product offers economic advnatages to the hospital in terms of more efficient use of high revenue producing laboratories and significantly improves patient comfort. Combined coronary and peripheral interventional markets: $1Billion
Team
-
Kelly ElliottClinical trial study diretor
Ms. Elliott is CEO of Eminence a Contract Research Organization (CRO) and Biostatistics and data management firm. She is a BSN MS registered nurse with considerable experience in the field of interventional cardiology
-
Karol George NowakowskiCSO
Mr. Nowakowski is the founder and inventor of the technology and sole inventor on the patents that protect the CloSys prducts and are assigned to the company. His experience includes directly related R&D at Angion and BBraun . He holds an MBA from the Carlson School at the University of MN and has particular expertise in patent strategy
-
Gervaise Lee WilhelmCEO
Ms Wilhelm is a veteran of 5 previous start up companies functioning founder, officer and director. Life Sciences have been the focus of each company. Exits have included both public offerings and acquistions by strategic organizations. Her credentials include certificaton by the American Soc of Cl Patholgoy, BS degree in Medical Technology and an MBA. She is a certified Physician Assistant in cardiopulmonary medicine.
-
Mary LachCFO
Ms. Lach has 25 years of experience working with large accounting firms (CPA) and with small companies. She has been a part of the CloSys organization since inception
-
Mary Beth HendersonRegulatory Affairs consultant
Dr. Henderson has 25 years of experience working with small and large companies as they interface with the FDA. Her experience includes quality systems development and management, global regulatory strategy development and execution and product and process development.
-
George Adams MDPrincipal Investigator Clinical trial
Dr. Adams is chief of interventional cardiology at Rex Heathcare in Raleigh, NC. He is actively involved in the emerging speciality of peripheral vascular interventional medicine. He is conducting clinical trials on innovative products designed to treat vascular disease using a catheter approach rather than with open surgical methods..
-
Bruce JohnsonChairman of the Board
Mr. Johnson served as inside counsel in Europe and in the US for Medtronic for more than 20 years. He is currently of counsel at Fredrikson and Byron a private law firm in Minneapolis where he serves in advisory capacity and board member to early stage medical device companies.
-
Kendall Price MDChief Hematology Consultant
Dr. Price is a practicing hematopathologist at HealthEast Clinical Pathology Laboratories in St. Paul, MN. He advises the company on product development matters. He is a graduate of the University of Chicago School of Medicine and hematopathologies residencies at Stanford University in Palo Alto, CA.
Advisors
-
Douglas Ramler - securities counsel Charles Sara Patent counselLawyerUnconfirmedMary Lach CPA; Wilkerson and Associates auditorsAccountantUnconfirmed
Previous Investors
-
Norris Institute Minneapolis, MNUnconfirmedThreshold Ventures Scottsdale, AZUnconfirmedHigh networth individuals Business AngelsUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.